NCT00152022View on ClinicalTrials.gov

Efficacy and Safety of SPD465 in Adults With Moderately Symptomatic ADHD.

PHASE3CompletedINTERVENTIONAL
Enrollment

412

Participants

Timeline

Start Date

April 25, 2005

Primary Completion Date

November 4, 2005

Study Completion Date

November 4, 2005

Conditions
Attention Deficit Disorder With Hyperactivity
Interventions
DRUG

Neutral salts of dextroamphetamine sulfate, USP, amphetamine sulphate, USP, d-amphetamine saccharate, d, l-amphetamine aspartate monohydrate.

Sponsors

Lead Sponsor

Shire
All Listed Sponsors
lead

Shire

INDUSTRY

NCT00152022 - Efficacy and Safety of SPD465 in Adults With Moderately Symptomatic ADHD. | Biotech Hunter | Biotech Hunter